Skip to main content
SLBTSL Science Holding LimitedSell4.2·$5.57+25.19%
SellModerate Confidence
Investment thesis

SL Science Holding shows weak fundamental quality (0/9 Piotroski, no moat) and a confirmed falling-knife downtrend (death cross, RSI 39, bearish MACD), and the engine's own asymmetry check models 0% upside even though a resistance-based price target implies 137% upside — a conflict the data does not resolve, keeping the stock flagged for exit.

Thesis pillars

  • Weak Quality No MoatStable
  • Confirmed Falling Knife DowntrendStable
  • Upside Estimate ConflictStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

SL Science Holding Limited (SLBT) Stock Analysis

Falling Knife setup

SellModerate Confidence

Healthcare · Biotechnology

Sell if holding. Engine safety override at $5.57: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.2/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. (Note: Risk dimension 0.0/10 and A.R:R 0.0:1 are different metrics that happen to read the same number here.)

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells,... Read more

$5.57+137.2% A.UpsideScore 4.2/10#230 of 253 Biotechnology
QualityF-score0 / 9FCF yield
Stop $5.57Target $14.21(resistance)A.R:R 0.0:1

Sell if holding. Engine safety override at $5.57: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.2/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. (Note: Risk dimension 0.0/10 and A.R:R 0.0:1 are different metrics that happen to read the same number here.) Chart setup: Death cross, below all MAs, RSI 39, MACD bearish. Score 4.2/10, moderate confidence.

Passes 6/9 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-06

Recent Developments — SL Science Holding Limited

Generated 2026-07-06T18:02:26Z.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (0.9 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)
Mkt Cap$3.4B
EV/EBITDA
Profit Mgn0.0%
ROE
Rev Growth
Beta
DividendNone
Rating analysts

Quality Signals

Piotroski F0/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Volatile — 42.8% daily ATR makes tight stops impractical. Position-size conservatively.static

Volatility
0.0
Low model confidence on this dimension (20%).

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Operating Margin
0.0
Net Margin
0.0
Piotroski F
0.0
Moat
4.5
No competitive moatWeak Piotroski F-Score: 0/9Quality concerns

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.4
Ma Position
1.0
Macd
3.0
Rsi
3.5
Obv
10.0
Volume accumulation (rising OBV)Below 200-MA, MA slope -4.3%/30d — confirmed downtrend
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Speculative
RSI
39 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $3.00Resistance $14.50

Price Targets

$6
$14
A.Upside+155.1%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (0.9 < 4.0)
! momentum at 3.6 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

We could not retrieve earnings history for SLBT.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is SLBT stock a buy right now?

Sell if holding. Engine safety override at $5.57: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.2/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. (Note: Risk dimension 0.0/10 and A.R:R 0.0:1 are different metrics that happen to read the same number here.) Chart setup: Death cross, below all MAs, RSI 39, MACD bearish. Prior stop was $5.57. Score 4.2/10, moderate confidence.

What is the SLBT stock price target?

Take-profit target: $14.21 (+137.2% upside). Prior stop was $5.57. Stop-loss: $5.57.

What are the risks of investing in SLBT?

Quality below floor (0.9 < 4.0).

Is SLBT overvalued or undervalued?

SL Science Holding Limited trades at a P/E of N/A (forward N/A). TrendMatrix value score: 5.0/10. Verdict: Sell.

0
What does SL Science Holding Limited do?SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL...

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Related stocks: CRMD (CorMedix Inc.) · ZVRA (Zevra Therapeutics, Inc.) · AUPH (Aurinia Pharmaceuticals Inc) · INCY (Incyte Corporation) · HRMY (Harmony Biosciences Holdings, I)
Home Stocks SLBT

Latest news

Latest News

Benzinga9h ago
Benzinga4d ago
Benzinga4d ago
Benzinga5d ago